FDA authorizes revisions to Evusheld dosing | FDA - FDA.gov
2/24/2022 12:00:00 AM3 years 2 months ago
by Center for Drug Evaluation and Research
by Center for Drug Evaluation and Research
FDA has revised the emergency use authorization for Evusheld (tixagevimab co-packaged with cilgavimab) to change the initial dose for the authorized used as pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and certain pediatric patients.
[2/24/2022] The U.S. Food and Drug Administration has revised the emergency use authorization for Evusheld (tixagevimab co-packaged with cilgavimab) to change the initial dose for the authorized use … [+4808 chars]
full article...